REFERENCES
- Dinarello CA. The proinflammatory cytokines inter-leukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991; 163: 1177-84.
- Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–4.
- Baker CJ. Group B streptococcal infections in new-borns. N Engl J Med 1986; 314: 1702–8.
- Teti G, Mancuso G, Tomasello F. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect Immun 1993; 61: 227–35.
- Mancuso G, Cusumano V, Cook JA, Smith E, Squadrito F, Blandino, Teti G. Efficacy of TNF inhibitors in neonatal sepsis models. FEMS Immunol Med Microbiol 1994; 9: 49–54.
- Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor alpha in intravascular and peritonitis models of sepsis. J Infect Dis 1991; 163: 83–8.
- Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159: 189–94.
- Maderazo EG, Breax S, Woronick CL, Krause PJ. Efficacy, toxicity, and pharmacokinetics of pentoxifylline and its analogs in experimental Staphylococcus aureus infections. Antimicrob Agents Chemother 1990; 34: 1100–1106.
- Short BL, Miller MK, Stroud CY, Fletcher JR. Comparison of thromboxane inhibitors to cydooxygenase inhibitors on survival in a newborn rat model for group B streptococcal sepsis. Adv Prostaglandin Thromboxane Leuko Res 1983; 12: 113–6.
- Zeligs BJ, Armstrong CD, Washer JB, Bellanti JA. Age-dependent susceptibility of neonatal rats to group B srepto-coccal type III infection: correlation of severity of infection and response of myeloid pools. Infect Immun 1982; 37: 255–63.